Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
Journal of Translational Medicine
Home
About
Articles
Submission Guidelines
Table 1
Summary of responses seen in 26 patients with refractory hematological malignancies treated with haploidentical PBSC infusions [
[
15
]
]
From:
Cellular immunotherapy for refractory hematological malignancies
Malignancy
Complete response
Partial response
Transient response
Total response
AML
3/13 (23%)
0/13 (0%)
7/13 (54%)
10/13 (77%)
NHL
2/6 (33%)
2/6 (33%)
0/6 (0%)
4/6 (66%)
Back to article page